Addressing COVID-19 vaccine hesitancy: is official communication the key?
Michaël Schwarzinger, Stéphane Luchini
Author Information
- Michaël Schwarzinger: Department of Methodology and Innovation in Prevention, Bordeaux University Hospital, 33000 Bordeaux, France; University of Bordeaux, Inserm UMR 1219-Bordeaux Population Health, Bordeaux, France. Electronic address: michael.schwarzinger@chu-bordeaux.fr.
- Stéphane Luchini: Aix-Marseille University, National Centre for Scientific Research (CNRS), School of Advanced Studies in the Social Sciences (EHESS), Ecole Centrale Marseille, Aix-Marseille School of Economics (AMSE), Marseille, France.
No abstract text available.
- Eur J Soc Psychol. 2021 Mar;51(2):285-293
[PMID: 33821057]
- Lancet Public Health. 2021 Jun;6(6):e416-e427
[PMID: 33991482]
- Nat Med. 2021 Feb;27(2):225-228
[PMID: 33082575]
- Psychol Med. 2022 Oct;52(14):3127-3141
[PMID: 33305716]
- Lancet Public Health. 2021 Apr;6(4):e210-e221
[PMID: 33556325]
- Nature. 2020 Jun;582(7811):230-233
[PMID: 32499650]
- J Public Health (Oxf). 2021 Dec 10;43(4):695-702
[PMID: 33693905]
- Public Health. 2021 May;194:86-88
[PMID: 33866149]
- R Soc Open Sci. 2020 Oct 14;7(10):201199
[PMID: 33204475]
COVID-19
COVID-19 Vaccines
Communication
Humans
SARS-CoV-2
Single-Blind Method
United Kingdom
Vaccination